Mr. Daniel Cohen reports

AURA ANNOUNCES APPOINTMENT OF NEW CHIEF EXECUTIVE OFFICER

Aura Health Inc. has appointed Daniel Cohen to the role of chief executive officer, effective immediately. Former CEO Chris Carl will continue to serve in his role as president and corporate secretary for Aura while Mr. Cohen assumes the role of CEO. Mr. Cohen has nearly 20 years of experience in the capital markets and most previously served as a partner and head of institutional equity sales at Beacon Securities. Prior to that, he held roles in institutional equity sales, investment banking and equity research at Wellington West Capital Markets, RBC Capital Markets and HSBC Securities. Mr. Cohen holds an MBA in finance from McGill University and is a CFA charterholder.

Mr. Cohen commented: "I am very pleased to be joining Aura and look forward to driving the development and execution of our corporate strategy going forward. In addition to the company's core clinics business, we intend to devote significant time and effort to pursuing international opportunities in medicinal cannabis, which we believe offers tremendous opportunity for value creation."

Chris Carl, president and corporate secretary, added: "We are very pleased to have Dan on board and look forward to leveraging his expertise and track record in steering Aura forward. Given our recent listing on the CSE, we believe the company is well positioned to capitalize on the current market demand for differentiated cannabis businesses and we look forward to Dan helping us develop that further at Aura."

About Aura Health Inc.

Aura, through its wholly owned Delaware subsidiary Green Global Properties Inc., has acquired a 30-per-cent interest in four entities operating four medical marijuana clinics in Las Vegas, Nev.; Mesa, Ariz.; Tucson, Ariz., and Hollywood, Fla. Green Global has an option to increase its interest in each such clinic (other than the Nevada clinic) from 30-per-cent to 51-per-cent exercisable within 18 months of the clinic opening.

We seek Safe Harbor.